Tobacco Centers of Regulatory Science (TCORS) (Clinical Trial Optional)
Funding Amount
Not stated
Deadline
Forecast — expected November 10, 2027
Forecast by the agency; not yet open
Grant Type
Federal
Deadline history & next window
- Cycle
- Not stated
- Next expected
- November 10, 2027
- Tracked since
- September 2026
Forecast: expected to post June 14, 2027; applications expected due November 10, 2027.
Source: Grants.gov forecast for this opportunity.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Nonprofits (501(c)(3))
- Private colleges & universities
- School districts
- Nonprofits without 501(c)(3) status
- Special district governments
- Public colleges & universities
- Small businesses
- Tribal organizations
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Overview
The Tobacco Regulatory Science Program, participating NIH Institutes and Centers (ICs), and the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) intend to issue a Notice of Funding Opportunity (NOFO) soliciting applications for Tobacco Centers of Regulatory Science (TCORS). The awards under this NOFO will be administered by NIH using funds made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31) (FSPTCA).
The TCORS program objective is to establish collaborative multidisciplinary research centers that will expand the scientific base informing regulation of tobacco products to protect public health and support implementation of the FSPTCA. Centers are expected to include at least three discrete hypothesis driven Research Projects with a scientific Integrative Theme.
The NOFO will solicit research applications within the regulatory authority of FDA CTP on one or more of the following topics:
- Addiction
- Behavior
- Communications
- Health Effects
- Impact Analysis
- Marketing
- Product Composition and Design
- Toxicity
Full eligibility text
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Focus Areas & Funding Uses
Fields of Work
- Health
Related Grants
Open grants from this funder and similar programs
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
National Institutes of Health
Amount
Varies
Deadline
October 6, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Ready to apply for Tobacco Centers of Regulatory Science (TCORS) (Clinical Trial Optional)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Tobacco Centers of Regulatory Science (TCORS) (Clinical Trial Optional). Now let's win it.